Recently in General Vaccination News Category

Legal immunity set for swine flu vaccine makers

|

By MIKE STOBBE (AP) - Jul 17, 2009

ATLANTA -- The last time the government embarked on a major vaccine campaign against a new swine flu, thousands filed claims contending they suffered side effects from the shots. This time, the government has already taken steps to head that off.

Vaccine makers and federal officials will be immune from lawsuits that result from any new swine flu vaccine, under a document signed by Secretary of Health and Human Services Kathleen Sebelius, government health officials said Friday.

Since the 1980s, the government has protected vaccine makers against lawsuits over the use of childhood vaccines. Instead, a federal court handles claims and decides who will be paid from a special fund.

Retired Vax Scientist Would Never Vaccinate His Kids

|
"If I had a child now, the last thing I would allow is vaccination."
-Retired Vaccine Researcher to Jon Rappoport

 
Editor's Note -- This interview was posted by Jon Rappoport in early January 2002. You will discover by reading it that the very issues we now face of FORCED vaccination of a laboratory-created vaccine to "protect" us against a laboratory-created "disease" (Swine Flu, Bird flu, etc.) was set into motion a long time ago.

The vaccine researcher quoted here flat out says that the World Homicide Organization, WHO, is driven by a DEPOPULATION agenda, and that many African leaders know full well that the explosive spread of HIV and AIDS in Africa was caused by WHO-sponsored vaccinations of the 1970s.

Novartis inks $500M anti-smoking vaccine pact

|

Novartis has demonstrated its commitment to the vaccine market with a $500 million (600 million Swiss francs) global licensing deal for Switzerland's Cytos Biotechnology's anti-smoking vaccine. Cytos gains 35 million Swiss francs up front for CYT002-NicQb, which is scheduled to go into late-stage trials in 2008. The rest of the money will be paid in scheduled milestones for a successful development program. Novartis takes over all development costs and responsibilities. NicQb works by spurring the development of antibodies that attach to nicotine molecules, making them too big to penetrate the blood-brain barrier, thereby reducing nicotine stimulation.

PAKISTAN: Religious leaders fight vaccine propaganda

|

vaccine shotISLAMABAD, 27 February 2007 (IRIN) - Muslim and community leaders are seeking to counter the disinformation surrounding polio vaccinations in parts of Pakistan's North West Frontier Province (NWFP) and tribal areas.

"To make people understand the importance of polio immunisation in an Islamic context is extremely important. We are engaging moderate religious leaders, community leaders and influential tribal elders. And we are holding community jirgas [councils] to address the concerns of the parents and ensure their children are vaccinated," said Melissa Corkum, a spokesperson for the United Nations Children's Fund (UNICEF) in the Pakistani capital, Islamabad.

The message is "that the polio vaccine is safe and that the same vaccine has been used to eradicate polio in other Muslim countries like Saudi Arabia and Indonesia", Corkum said. 

Muslim urged to shun 'unholy' vaccines

|

A MUSLIM doctors’ leader has provoked an outcry by urging British Muslims not to vaccinate their children against diseases such as measles, mumps and rubella because it is “un-Islamic”.

Dr Abdul Majid Katme, head of the Islamic Medical Association, is telling Muslims that almost all vaccines contain products derived from animal and human tissue, which make them “haram”, or unlawful for Muslims to take.
Islam permits only the consumption of halal products, where the animal has had its throat cut and bled to death while God’s name is invoked.

Islam also forbids the eating of any pig meat, which Katme says is another reason why vaccines should be avoided, as some contain or have been made using pork-based gelatine.

novartis BASEL (AFX) - Novartis AG said it has received a contract from the US health department worth approximately 55 mln usd to further develop a novel antigen technology that could extend vaccine supplies in a pandemic outbreak.

The contract supports the company's efforts to develop and manufacture its MF59 adjuvant in the US, the Basel-based drug maker said.

An adjuvant is a substance added to a vaccine to enhance the body's immune response to the vaccine's active constituent.

source - AFX 

When There Is No Vaccine

|

Passive immunization is the answer.

Author: Jack Woodall

In 1942, long before the vaccine was available, I contracted measles, went into a coma, but recovered. My younger brother and sister received transfusions of immune serum from our mother, who had had measles as a child, and were protected. My siblings were not the only ones to benefit from serum treatment: In 1970, two people working on Lassa fever at a university research lab caught the illness, and one died. The other was diagnosed in time, received immune serum from a Lassa survivor, and recovered.

Vaccines have saved countless lives. But there are still diseases that cause large numbers of cases and deaths, such as dengue and malaria, for which vaccines have been sought for decades but always seem to be five years in the future. Other important diseases like Ebola and Lassa fevers are crying out for vaccines, which are under development but still predicted to take years before they will be generally available.

CDC Updates Kids' Vaccine Schedule

|

vaccination for childrenJan. 5, 2007 -- The CDC has released its 2007 recommended vaccination schedule for kids 0-18 years old.

The schedule includes two new vaccines and tweaks to recommended flu and chickenpox vaccination.

One of the two new vaccines targets certain strains of human papillomavirus (HPV), a leading cause of cervical cancer.

The CDC recommends routine HPV vaccination for girls 11-12 years old. Girls can get the vaccine when they're as young as 9 years old.

global vaccinationThe advance market commitment plan aimed at funding the development of vaccines for diseases -- including HIV/AIDS, tuberculosis and malaria -- that largely affect developing countries is "a new way for partners in the private and public sectors to solve an old problem," Orin Levine, an associate professor of international health at the Johns Hopkins University Bloomberg School of Public Health, and Michael Klag, the Bloomberg school's dean, write in a Baltimore Sun opinion piece (Levine/Klag, Baltimore Sun, 1/3).

Under the plan, the Group of Eight industrialized nations would provide between $800 million and $6 billion to subsidize the purchase of new vaccines. Wealthy nations also would provide funding to pharmaceutical companies when they produce safe and effective vaccines, and drug makers would sell the vaccines at reduced prices in developing countries when G8 nations have provided the promised amount. 

vaccination for kidsMore than six-thousand students in the Maryland suburbs of Washington were kept out of classes yesterday because they did not have the proper record of vaccinations.

A law requiring students in sixth through ninth grades to provide records of chickenpox and hepatitis B vaccinations took effect with the new year.

The only exceptions were for those who had proof with proof of appointments to get the shots by January 22nd.